SCHEMBL905414

SCHEMBL905414

CCCC/C(=C\C#N)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.40
APEX1 P27695 1/20 0.40
CES2 O00748 1/20 0.39
ALDH1A1 P00352 3/20 0.37
AKR1B1 P15121 1/20 0.37
TP53 P04637 1/20 0.37
GPR84 Q9NQS5 7/20 0.35
PPARG P37231 7/20 0.35
PPARD Q03181 7/20 0.35
PPARA Q07869 7/20 0.35
HDAC11 Q96DB2 5/20 0.35
TSHR P16473 4/20 0.35
PTPN1 P18031 3/20 0.35
TLR2 O60603 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
FABP4 P15090 2/20 0.35
SLC22A6 Q4U2R8 1/20 0.35
SLC22A8 Q8TCC7 1/20 0.35
MEN1 O00255 1/20 0.35
ESR1 P03372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL147781 1.00 CES1 (0.40) CES1APEX1CES2ALDH1A1AKR1B1
SCHEMBL147780 1.00 CES1 (0.40) CES1APEX1CES2ALDH1A1AKR1B1
SCHEMBL5885411 0.94 APEX1 (0.37) CES1APEX1CES2ALDH1A1AKR1B1
SCHEMBL1275312 0.94 AKR1B1 (0.45) CES1APEX1CES2ALDH1A1AKR1B1
SCHEMBL1275314 0.94 AKR1B1 (0.45) CES1APEX1CES2ALDH1A1AKR1B1
SCHEMBL487304 0.92 GPR84 (0.47) CES1APEX1CES2ALDH1A1AKR1B1
SCHEMBL423100 0.92 GPR84 (0.47) CES1APEX1CES2ALDH1A1AKR1B1
SCHEMBL423101 0.92 GPR84 (0.47) CES1APEX1CES2ALDH1A1AKR1B1
SCHEMBL154903 0.92 GPR84 (0.47) CES1APEX1CES2ALDH1A1AKR1B1
SCHEMBL142753 0.92 GPR84 (0.47) CES1APEX1CES2ALDH1A1AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2273986-A2 ENCAPSULATION OF BIOLOGICALLY ACTIVE AGENTS Glaxo Group Limited (GB) 2011-01-19 EP disclosed
EP-2271324-A2 ENCAPSULATION OF BIOLOGICALLY ACTIVE AGENTS Glaxo Group Limited (GB) 2011-01-12 EP disclosed
WO-2009135855-A2 ENCAPSULATION OF BIOLOGICALLY ACTIVE AGENTS GLAXO GROUP LIMITED (GB) 2009-11-12 WO disclosed
WO-2009135854-A2 ENCAPSULATION OF BIOLOGICALLY ACTIVE AGENTS GLAXO GROUP LIMITED (GB) 2009-11-12 WO disclosed